Quantitative characterization of neuronal trans-SNARE complexes using DNA origami
Quantitative characterization of neuronal trans-SNARE complexes using DNA origami
批准号:
10281683
负责人:
Zhao Zhang
金额:
$41.43万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-15 至 2023-12-31
关键词:
AffectBasic ScienceBindingCell membraneCleaved cellClostridial NeurotoxinComplexConsensusDNADNA StructureDiseaseDockingElectron MicroscopeEnvironmentExocytosisFreezingIn VitroIndividualInvestigationKnowledgeLengthLibrariesLipid BilayersLipidsMeasurementMediatingMembraneMembrane FusionMembrane ProteinsMental disordersMethodsMolecular ConformationMutationNanotechnologyNeuraxisNeuronsNeurosciencesNeurotoxicity SyndromesNeurotoxinsOpticsPathogenesisPlayPositioning AttributeProbabilityProcessProteinsResearchResistanceRoleS-nitro-N-acetylpenicillamineSNAP receptorSpectrum AnalysisStructureSynapsesSynaptic CleftSynaptic ReceptorsSynaptic VesiclesTechniquesTechnologyTransmembrane DomainVesicleVisualizationalpha helixarmbaseclinical practicedensitydriving forceexperimental studygenetic regulatory proteinhuman diseaseimprovedinterestmechanical propertiesmutantnanodisknanoscaleneurophysiologyneurotransmissionneurotransmitter releasenovelpreventprogramsprotein complexprotein functionreconstitutionrecruitscaffoldsingle moleculestemsynaptotagmin Isyntaxintooltransmission processvesicle-associated membrane protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
A key step in neurotransmission is the fusion of the synaptic vesicle (SV) membrane with neuronal
plasma membrane (PM), to release neurotransmitters into the synaptic cleft where they bind and activate post
synaptic receptors. A protein complex called SNARE is believed to play a central role since its assembly can
generate enough energy to drive fusion. The current hypothesis that describes SNARE-mediated fusion is
referred to as 'SNARE zippering': a v-SNARE protein on SV binds to a t-SNARE protein heterodimer on PM in
a zipper-like fashion, forming a trans-SNARE complex (i.e. v- and t-SNARE transmembrane domains are
embedded in separate membranes); the released energy eventually overcomes the repulsive forces between
SV and PM and pulls the two membranes together, where trans-SNARE complexes transform into cis-SNARE
complexes (i.e. v- and t-SNAREs locate on a single membrane). At present most of what is known concerning
neuronal SNARE structure and dynamics stems from analysis of cis-SNARE, but the 'real hero' trans-SNARE
that provides the driving force for membrane fusion remains elusive. A main technical challenge here is to
capture partially assembled trans-SNARE complexes that form during the fast process of exocytosis (<1 ms).
In this proposal, we offer a solution by combining the power of nanoscale programmability from DNA
nanotechnology and the ability of restricting fusion pore expansion by using nanodisc (ND). A V-shaped DNA
origami structure is used for hosting two binding moieties; one moiety comprises v-SNAREs that have been
reconstituted in NDs, while the other comprises NDs with the cognate t-SNAREs. Our platform significantly
improved previous methods in revealing true information of neuronal trans-SNARE assembly by studying: (1)
full-length SNARE proteins rather than truncations or mutations, as the disruption of zippering solely arises
from distance control; (2) SNAREs in lipid bilayers, which represent their native environment.
In Specific Aim 1, a set of partially-assembled neuronal trans-SNARE complexes residing in bilayers are
produced, which mimic the progressive quaternary core in synaptic fusion machinery. Then various clostridial
neurotoxins (CNTs) are added into the complex set, and the relation between SNARE assembly completeness
and CNTs' proteolytic activity could be systematically examined. In Specific Aim 2, a modified V-origami
functions as a force spectrometer to investigate the energy landscape of neuronal trans-SNARE assembly in
the context of bilayers. Importantly, we will examine the effect of disease-associated SNARE mutations on
trans-complex assembly energy, which would help elucidate their impact on psychiatric disorders.
In brief, we strive to build a novel and powerful platform to revisit one of the central yet elusive machinery
in neuroscience: the neuronal trans-SNARE complex. Important knowledge concerning widely-used CNTs and
disease-relevant mutants are expected to acquire in this study, potentially benefiting both basic research and
clinical practices. Such DNA-based technology may also be used to study other membrane proteins in vitro.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease
-
批准号:10544345
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2022
-
负责人:Zhao Zhang
-
依托单位:
The Role of Gm4951 in Nonalcoholic Fatty Liver Disease
-
批准号:10339213
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2022
-
负责人:Zhao Zhang
-
依托单位:
Regulation, function, and impact of developmental retrotransposon activation
-
批准号:10177576
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2021
-
负责人:Zhao Zhang
-
依托单位:
Regulation, function, and impact of developmental retrotransposon activation
-
批准号:10549855
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2021
-
负责人:Zhao Zhang
-
依托单位:
Regulation, function, and impact of developmental retrotransposon activation
-
批准号:10373055
-
项目类别:
-
资助金额:$32.68万
-
财政年份:2021
-
负责人:Zhao Zhang
-
依托单位:
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes
-
批准号:10468738
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Zhao Zhang
-
依托单位:
The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes
-
批准号:10213315
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Zhao Zhang
-
依托单位:
Somatic transposition-mediated genome variegation during development, disease and aging conditions
-
批准号:9001476
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2015
-
负责人:Zhao Zhang
-
依托单位:
Somatic transposition-mediated genome variegation during development, disease and aging conditions
-
批准号:10043992
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2015
-
负责人:Zhao Zhang
-
依托单位:
Somatic transposition-mediated genome variegation during development, disease and aging conditions
-
批准号:9349391
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2015
-
负责人:Zhao Zhang
-
依托单位:
海外基金